SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹415 Cr | ₹389 Cr | ₹336 Cr | ₹268 Cr | ₹178 Cr |
What is the latest Total Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹415 Cr |
| Mar2024 | ₹389 Cr |
| Mar2023 | ₹336 Cr |
| Mar2022 | ₹268 Cr |
| Mar2021 | ₹178 Cr |
How is Total Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹415 Cr | 6.84 | |
| Mar2024 | ₹389 Cr | 15.56 | |
| Mar2023 | ₹336 Cr | 25.61 | |
| Mar2022 | ₹268 Cr | 50.61 | |
| Mar2021 | ₹178 Cr | - | |
Compare Total Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹902.5 Cr | -2.4% | 5.3% | 37.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | -2.4% |
5.3% |
37.3% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses